| Website | ekoscorp.com |
| Category | BioTech |
| Phone | 888-400-3567 |
| Ekosmarketing@eko... | |
| Employees | |
| Founded | 1995 |
| TOTAL | $44M |
| FUNDING TOTAL | $44M |
| Series B, 2/05 NGN Capital MedVenture Associates Morgan Stanley EGS Healthcare Capital Partners | $18M |
| Series C, 3/06 Ascension Health Ventures Oakwood Medical Investors Trellis Partners CID Equity Capital EGS Healthcare Capital Partners MedVenture Associates Mitsui Ventures Morgan Stanley Venture Partners NGN Capital | $26M |
EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to provide faster, safer and more complete dissolution of thrombus.
